BIOTRONIK Inc recalls BIOTRONIK ITREVIA 7, VR-T DF-1, REF 393040, UDI: 04035479129552 - Product Usage: intended to provide ventricular tachyc…
- Recall date
- March 8, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1451-2021
- FDA classification
- Class II
- Brand / firm
- BIOTRONIK Inc
- Sold / distributed
- US: Nationwide OUS: Worldwide
Why it was recalled
There is a potential for premature battery depletion in Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy Defibrillators (CRT'Ds)
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
BIOTRONIK ITREVIA 7, VR-T DF-1, REF 393040, UDI: 04035479129552 - Product Usage: intended to provide ventricular tachycardia pacing and ventricular defibrillation for automatic treatment of life-threatening ventricular arrhythmias.
Get recall alerts
Free email alert whenever BIOTRONIK Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: BIOTRONIK Inc